Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose Olokizumab (CDP6038) in RA
NCT01009242Phase 2Completed
- Sponsor
- UCB
- Start
- Oct 2009
- Primary completion
- Sep 2010
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of olokizumab in rheumatoid arthritis (RA), sponsored by UCB. Started Oct 2009; status: completed.
02
Drugs
olokizumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01009242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01009242.